Marker Therapeutics, Inc. SEC filings MRKR
Marker Therapeutics, Inc. has 904 filings in SEC EDGAR's recent list, going back to Sep 3, 1999. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B7 | Filing | Aug 5, 2025 | — |
| 424B3 | Prospectus | Jan 17, 2025 | — |
| S-3 | Shelf registration | Jan 10, 2025 | — |
| 424B3 | Prospectus | Dec 6, 2024 | — |
| S-3 | Shelf registration | Nov 27, 2024 | — |
| 424B5 | Prospectus supplement | Mar 22, 2023 | — |
| 424B3 | Prospectus | Jan 3, 2023 | — |
| S-1 | Registration statement | Dec 23, 2022 | — |
| S-8 | Employee stock plan registration | Aug 11, 2022 | — |
| 424B5 | Prospectus supplement | Mar 18, 2022 | — |
| S-3 | Shelf registration | Aug 10, 2021 | — |
| 424B5 | Prospectus supplement | Mar 15, 2021 | — |
| 424B5 | Prospectus supplement | Mar 11, 2021 | — |
| S-8 | Employee stock plan registration | Jun 12, 2020 | — |
| 424B5 | Prospectus supplement | Mar 3, 2020 | — |
| S-3 | Shelf registration | Jun 14, 2019 | — |
| 424B7 | Filing | Jan 29, 2019 | — |
| 424B3 | Prospectus | Nov 16, 2018 | — |
| S-3 | Shelf registration | Oct 30, 2018 | — |
| S-8 | Employee stock plan registration | Oct 30, 2018 | — |
| 424B7 | Filing | Jun 21, 2018 | — |
| 424B7 | Filing | Jun 15, 2018 | — |
| S-8 | Employee stock plan registration | Mar 23, 2018 | — |
| 424B3 | Prospectus | Dec 29, 2017 | — |
| S-3/A | Filing | Dec 28, 2017 | — |
| S-3/A | Filing | Sep 22, 2017 | — |
| S-3 | Shelf registration | Sep 20, 2017 | — |
| 424B3 | Prospectus | Jan 19, 2017 | — |
| S-3 | Shelf registration | Dec 22, 2016 | — |
| 424B3 | Prospectus | Nov 7, 2016 | — |
| 424B3 | Prospectus | Sep 15, 2016 | — |
| 424B3 | Prospectus | Aug 15, 2016 | — |
| 424B3 | Prospectus | Jun 10, 2016 | — |
| POS AM | Post effective amendment no. 2 | Jun 2, 2016 | — |
| POS AM | Post effective amendment no. 1 | May 12, 2016 | — |
| 424B3 | Prospectus | Nov 20, 2015 | — |
| 424B3 | Prospectus | Nov 20, 2015 | — |
| 424B3 | Prospectus | Aug 11, 2015 | — |
| S-1 | Registration statement | Jul 20, 2015 | — |
| 424B3 | Prospectus | Jul 17, 2015 | — |
| POS AM | Filing | Jul 8, 2015 | — |
| POS AM | Filing | Jun 19, 2015 | — |
| 424B5 | Prospectus supplement | Mar 9, 2015 | — |
| 424B5 | Prospectus supplement | Jan 12, 2015 | — |
| 424B5 | Prospectus supplement | Aug 13, 2014 | — |
| S-3/A | Filing | Jul 21, 2014 | — |
| S-3 | Shelf registration | May 20, 2014 | — |
| 424B3 | Prospectus | Aug 6, 2010 | — |
| S-1/A | Amended registration statement | Aug 4, 2010 | — |
| S-1/A | Amended registration statement | Aug 2, 2010 | — |
| S-1 | Registration statement | Jun 16, 2010 | — |
| S-8 POS | Form s-8 amendment #1 | Apr 27, 2004 | — |
| S-8 | Employee stock plan registration | Jan 29, 2004 | — |
| S-8 | Employee stock plan registration | Aug 12, 2003 | — |
| S-8 | Employee stock plan registration | Jul 18, 2002 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MRKR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1094038
- Former names
- TAPIMMUNE INC. (until Oct 17, 2018); TAPIMMUNE INC (until Jun 29, 2017); GENEMAX CORP (until Jun 28, 2007); EDUVERSE COM (until Jun 17, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.